«
»

Sequenom says SEC probes Down Syndrome test (Reuters)

Reuters – Sequenom Inc said the U.S. Securities and Exchange Commission has initiated an investigation related to the company’s Down Syndrome test SEQureDx, sending its shares down 8 percent.

This entry was posted on Tuesday, June 30th, 2009 at 10:33 pm and is filed under Calator. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.